Extrovis EU is an API manufacturer based in Switzerland. It holds 8 active US drug master files and one valid CEP across a filed portfolio of 8 molecules. Its filings concentrate with US FDA, EMA and FAMHP (BE).
| Site | FDA FEI |
|---|---|
| Baar, Switzerland | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Dapsone | EDQM, US FDA | 2 |
| Avibactam | US FDA | 1 |
| Calcium Gluconate | US FDA | 1 |
| Dipotassium Phosphate | US FDA | 1 |
| Eltrombopag | US FDA | 1 |
| Monopotassium Phosphate | US FDA | 1 |
| Tolvaptan | US FDA | 1 |
| Trabectedin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 24 | None |
| EMA | 5 | None |
| FAMHP (BE) | 4 | None |
| AIFA (IT) | 4 | None |
| INFARMED (PT) | 3 | None |
| MPA (SE) | 2 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Extrovis EU comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.